Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation-Reference-Cited by-同舟云学术

Current Results and Future Research Priorities in Late Effects after Hematopoietic Stem Cell Transplantation for Children with Sickle Cell Disease and Thalassemia: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric Hematopoietic Stem Cell Transplantation

Published:2017-04 Issue:4 Volume:23 Page:552-561
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Shenoy Shalini,Angelucci Emanuele,Arnold Staci D.,Baker K. Scott,Bhatia Monica,Bresters Dorine,Dietz Andrew C.,De La Fuente Josu,Duncan Christine,Gaziev Javid,King Allison A.,Pulsipher Michael A.,Smith Angela R.,Walters Mark C.

Funder

Children's Discovery Institute of Washington University

St. Louis Children's Hospital

National Heart, Lung, and Blood Institute

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference98 articles.

1. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy;Lucarelli;N Engl J Med,1993